Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 22415229)

1.

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome.

Krakstad C, Trovik J, Wik E, Engelsen IB, Werner HM, Birkeland E, Raeder MB, Øyan AM, Stefansson IM, Kalland KH, Akslen LA, Salvesen HB.

Br J Cancer. 2012 May 8;106(10):1682-8. doi: 10.1038/bjc.2012.91. Epub 2012 Mar 13.

2.

G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.

Skrzypczak M, Schüler S, Lattrich C, Ignatov A, Ortmann O, Treeck O.

Steroids. 2013 Nov;78(11):1087-91. doi: 10.1016/j.steroids.2013.07.007. Epub 2013 Aug 3.

PMID:
23921077
3.

GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival.

Engelsen IB, Stefansson IM, Akslen LA, Salvesen HB.

Am J Obstet Gynecol. 2008 Nov;199(5):543.e1-7. doi: 10.1016/j.ajog.2008.04.043. Epub 2008 Jul 3.

PMID:
18599012
4.

Expression of G protein-coupled estrogen receptor in irritable bowel syndrome and its clinical significance.

Qin B, Dong L, Guo X, Jiang J, He Y, Wang X, Li L, Zhao J.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2238-46. eCollection 2014.

5.

Switch in FOXA1 status associates with endometrial cancer progression.

Tangen IL, Krakstad C, Halle MK, Werner HM, Oyan AM, Kusonmano K, Petersen K, Kalland KH, Akslen LA, Trovik J, Hurtado A, Salvesen HB.

PLoS One. 2014 May 21;9(5):e98069. doi: 10.1371/journal.pone.0098069. eCollection 2014.

6.

[Effect of GPER on the activation of PI3K/Akt induced by 17β-estradiol in endometrial carcinoma cells].

Zhang YC, Guo RX, Ge X, Qiao YH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Apr;47(4):292-6. Chinese.

PMID:
22781117
7.

Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells.

Imesch P, Samartzis EP, Dedes KJ, Fink D, Fedier A.

Fertil Steril. 2013 Sep;100(3):770-6. doi: 10.1016/j.fertnstert.2013.05.008. Epub 2013 Jun 10.

PMID:
23755949
9.
10.

Estrogen-related receptor-γ regulates estrogen receptor-α responsiveness in uterine endometrial cancer.

Yamamoto T, Mori T, Sawada M, Kuroboshi H, Tatsumi H, Yoshioka T, Matsushima H, Iwasaku K, Kitawaki J.

Int J Gynecol Cancer. 2012 Nov;22(9):1509-16. doi: 10.1097/IGC.0b013e31826fd623.

PMID:
23051957
11.

MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.

Lappano R, Santolla MF, Pupo M, Sinicropi MS, Caruso A, Rosano C, Maggiolini M.

Breast Cancer Res. 2012 Jan 17;14(1):R12.

12.

G-protein Coupled Estrogen Receptor 1 Expression in Primary Breast Cancers and Its Correlation with Clinicopathological Variables.

Luo HJ, Luo P, Yang GL, Peng QL, Liu MR, Tu G.

J Breast Cancer. 2011 Sep;14(3):185-90. doi: 10.4048/jbc.2011.14.3.185. Epub 2011 Sep 29.

13.

Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions.

Tangen IL, Werner HM, Berg A, Halle MK, Kusonmano K, Trovik J, Hoivik EA, Mills GB, Krakstad C, Salvesen HB.

Eur J Cancer. 2014 Nov;50(17):3003-10. doi: 10.1016/j.ejca.2014.09.003. Epub 2014 Sep 30.

PMID:
25281525
14.

Insulin-like growth factor-I regulates GPER expression and function in cancer cells.

De Marco P, Bartella V, Vivacqua A, Lappano R, Santolla MF, Morcavallo A, Pezzi V, Belfiore A, Maggiolini M.

Oncogene. 2013 Feb 7;32(6):678-88. doi: 10.1038/onc.2012.97. Epub 2012 Mar 19.

PMID:
22430216
15.

Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study.

Samartzis N, Samartzis EP, Noske A, Fedier A, Dedes KJ, Caduff R, Fink D, Imesch P.

Reprod Biol Endocrinol. 2012 Apr 20;10:30. doi: 10.1186/1477-7827-10-30.

16.

[Expression of estrogen receptor-related receptor isoforms in endometrial carcinoma tissues and its clinical significance].

Gao M, Wei LH, Sun PM, Zhao D, Wang JL, Wang ZQ, Zhao C.

Zhonghua Fu Chan Ke Za Zhi. 2005 Nov;40(11):756-60. Chinese.

PMID:
16324250
17.

High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.

Marot D, Bieche I, Aumas C, Esselin S, Bouquet C, Vacher S, Lazennec G, Perricaudet M, Kuttenn F, Lidereau R, de Roux N.

Endocr Relat Cancer. 2007 Sep;14(3):691-702.

18.

PIK3CA mutations in endometrial carcinomas in Chinese women: phosphatidylinositol 3'-kinase pathway alterations might be associated with favorable prognosis.

Dong Y, Yang X, Wong O, Zhang X, Liang Y, Zhang Y, Wong W, Nong L, Liao Q, Li T.

Hum Pathol. 2012 Aug;43(8):1197-205. doi: 10.1016/j.humpath.2011.08.021. Epub 2011 Dec 30.

PMID:
22209294
19.

Towards individualisation of treatment in endometrial cancer.

Taylor SE, Green JA.

Br J Cancer. 2012 May 8;106(10):1581-2. doi: 10.1038/bjc.2012.140. No abstract available.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk